(Press-News.org) Graduates who went to medical school for three years performed equally well on tests of skill and knowledge as their peers who followed a four-year program, a new study shows.
The accelerated three-year MD pathway offered by NYU Grossman School of Medicine beginning in 2013 was designed to help students earn their medical degrees sooner with reduced debt, which some experts say reaches $250,000 on average by graduation. The school was the first in the United States to offer a three-year MD program that provides a direct pathway to all of its 21 residency training programs, wherein new physicians become specialists in areas such as such as internal medicine, emergency medicine, and surgery. However, whether the shorter track provides as rigorous an education as more typical ones had until now remained unclear.
While experts have previously examined academic performance in such training systems, the authors say their new study, publishing online Oct. 15 in the journal Academic Medicine, is the largest evaluation of programs opening in the last decade.
In the new analysis, the study authors found that 136 accelerated graduates scored comparably on metrics taken during medical school and residency as 681 of their four-year-program peers. For example, the three-year students earned an average score of 84% on their preclerkship exams, which evaluated their grasp of topics that included anatomy, cell biology, and biochemistry. Their four-year counterparts scored 83% on average. Both groups also achieved similar marks on medical knowledge and clinical skills exams, as well as on tests of critical thinking and communication based on multiple mini-interviews.
“Our findings suggest that accelerated curriculums offer an efficient, cost-effective way to prepare medical students for the next stage of training without compromising on the quality,” said study senior author Joan Cangiarella, MD. Cangiarella is the pathway’s director and the Elaine Langone Professor of Pathology in the Department of Pathology at NYU Grossman School of Medicine.
In four-year schooling, students spend much of their fourth year taking electives, such as surgery, orthopedics, and otolaryngology, among others, to decide what specialty to pursue. Then, they apply to be matched with openings in residencies available in hospitals throughout the country.
By contrast, the fast-tracked option was developed for those who have chosen their career path early on in their studies, notes Cangiarella, also the senior associate dean for education, faculty, and academic affairs at NYU Grossman School of Medicine. Although they learn the same core curriculum as their peers, these students also receive research opportunities and individualized mentorship from faculty members in their chosen specialty. Then, provided they continue to perform well academically, they have a direct pathway to a residency within NYU Langone Health or can instead elect to be matched elsewhere after completing year three. NYU Grossman School of Medicine is part of a consortium, of which Cangiarella is the chair, of over 30 medical schools in the United States with a three-year program.
For the research, the study team collected demographic data and test scores from those who graduated from the school’s condensed program between 2016 and 2022 and from those who graduated from its standard track between 2017 and 2023.
“Accelerated medical-school paths not only benefit students by saving a year of tuition and by enabling an extra year of earnings, they also provide residencies with trainees who are tailor-made for them,” said study co-author Steven Abramson, MD. Abramson is the Frederick H. King Professor of Internal Medicine in NYU Grossman School of Medicine’s Department of Medicine, for which he also serves as chair, and is the school’s executive vice president and vice dean for education, faculty, and academic affairs.
“The clear success of our fast-tracked system has prompted major changes in our overall curriculum,” said study co-author Elisabeth Cohen, MD. “As of 2023, we now enable all students to graduate in three years if they choose, whether they proceed directly to a residency here or get matched elsewhere.” Cohen is a professor and vice chair for academic affairs in the Department of Ophthalmology at NYU Grossman School of Medicine and is the advisor to its accelerated students.
Although graduates of the condensed program scored equally well as their four-year counterparts on preclinical and clinical knowledge exams, they earned lower scores on parts of the U.S. Medical Licensing Exam taken during medical school, according to the study results. This is likely because they had less time to study and had a direct pathway to a residency, the authors say. Still, they performed just as well as their four-year peers on the part of the exam that is taken at the end of the first year of residency.
Cohen adds that the authors plan to expand their study to include graduates of similar training systems in medical schools worldwide.
Study funding was provided by the Josiah Macy Jr. Foundation.
Along with Cangiarella, Abramson, and Cohen, other NYU Langone investigators involved in the study are lead author Nivedha Satyamoorthi, MS, and co-authors Marina Marin, MSc; Peter Ludlow, MPhys; Marc Triola, MD; and Colleen Gillespie, PhD.
A graduate of the accelerated three-year MD pathway is available for comment upon request.
Media Inquiries:
Shira Polan
Phone: 212-404-4279
shira.polan@nyulangone.org
David March (for Oct. 14 only, Columbus Day)
212-404-3528
david.march@nyulangone.org
END
Accelerated three-year medical school students perform as well as peers in traditional four-year programs
2024-10-15
ELSE PRESS RELEASES FROM THIS DATE:
SwRI-developed instruments will study potential habitability of Jupiter’s moon Europa
2024-10-15
SAN ANTONIO — October 15, 2024 —Two Southwest Research Institute instruments were launched aboard NASA’s Europa Clipper spacecraft on Oct. 14 from the agency’s Kennedy Space Center. The spacecraft is designed to conduct a detailed reconnaissance of Jupiter’s moon Europa, investigating whether it could hold conditions suitable for life.
The SwRI-developed MAss Spectrometer for Planetary EXploration (MASPEX) and Ultraviolet Spectrograph (Europa-UVS) are among nine science instruments and a gravity science investigation that were developed to explore Europa, Jupiter’s fourth-largest ...
Proposed scoring system may enhance equity in organ transplantation, increase transplant rates and improve patient survival
2024-10-15
Tuesday, Oct. 15, 2024, Cleveland: Researchers at Cleveland Clinic and Case Western Reserve University (CWRU) have developed a new method that could potentially help provide better access to lung transplant for transplant candidates who are hard to match because of their blood type or height.
An analysis published in the Journal of Heart & Lung Transplantation showed significant inequity in lung transplant access based on these candidate characteristics and proposes a method for addressing it.
Lung transplant candidates require organs from donors of similar height and compatible blood type. Currently, to allow equally sick candidates equal ...
Survivors of childhood brain cancer are more likely to be held back in school
2024-10-15
In 2019, Raymond Mailhot was visiting with a young patient and his family facing a scary diagnosis – brain cancer. Treatments were incredibly effective, and the young boy was going to survive, Mailhot shared in Spanish with the Venezuelan immigrants.
But life would be disrupted at home, at the hospital, and at school, likely for months, he said.
“His story really made me want to dig deeper into the scholastic performance of survivors,” said Mailhot, M.D., M.P.H, an associate professor of radiation oncology at the University of Florida. “We discovered that survivors had twice the odds of being held back and performed significantly worse on state testing ...
Updating offshore turbine designs to reflect storms’ complexity is key
2024-10-15
WASHINGTON, Oct. 15, 2024 – The U.S. is ramping up plans for a major increase in offshore wind production, with 30 gigawatts of new installations expected by 2030 and a total of 110 gigawatts by 2050. But to be successful, the country needs to design turbines that can withstand the challenges of tropical storms.
“Extreme weather impacts on offshore wind turbines are not fully understood by the industry,” author Jiali Wang said. “Manufacturers design wind turbines based on international design standards, but better models and data are needed to study the impacts of extreme weather ...
Hospital strain during the COVID-19 pandemic and outcomes in older racial and ethnic minority adults
2024-10-15
About The Study: In this cross-sectional study, older adults hospitalized with sepsis were more likely to die or experience major morbidity as the hospital COVID-19 burden increased. These increases in adverse outcomes were greater in magnitude among members of minority populations than for white individuals.
Corresponding Author: To contact the corresponding author, Laurent G. Glance, MD, email laurent_glance@urmc.rochester.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.38563)
Editor’s Note: Please see the article for additional information, ...
Scientists unveils key role of “selfish DNA” in early human development
2024-10-15
A critical transition in early human development is regulated not by our own genes, but by DNA elements called transposons that can move around the genome, Sinai Health researchers have found.
This remarkable discovery challenges our previous understanding of these elusive DNA segments, shedding new light on the roles they play in human development and disease.
“People tend to think of transposons as akin to viruses where they hijack our cells for the sole purpose of propagating themselves,” says study’s senior co-author Dr. Miguel Ramalho-Santos, Senior Investigator at the Lunenfeld-Tanenbaum Research Institute (LTRI), part of Sinai Health, and Professor ...
Bonobos may be more vulnerable than previously thought, suggests genetics study
2024-10-15
Bonobos, endangered great apes that are among our closest relatives, might be more vulnerable than previously understood, finds a genetics study led by a UCL researcher that reveals three distinct populations.
The three groups of bonobos have been living separately in different regions in Central Africa for tens of thousands of years, according to the study published in Current Biology by an international research team co-led by UCL, University of Vienna, and Max Planck Institute for Evolutionary Anthropology ...
Scripps Research scientists discover chemical probes for previously “undruggable” cancer target
2024-10-15
LA JOLLA, CA—Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein called Forkhead box protein 1 (FOXA1). FOXA1 mutations can enable these types of cancers to grow and proliferate. Today, FOXA1 is notoriously difficult to block with drugs—but that may soon change.
Scripps Research scientists have identified a crucial binding site on FOXA1 that could pave the way for future cancer treatments. The team’s findings, which were published in Molecular Cell on October 15, 2024, also mapped out how tiny drug-like chemical compounds—called small molecules—interact with the protein.
While ...
Giant Magellan telescope begins primary mirror support system testing
2024-10-15
TUCSON, AZ — October 15, 2024 — The Giant Magellan Telescope today announced the successful installation of one of its completed 8.4-meter-diameter primary mirrors into a support system prototype at the University of Arizona’s Richard F. Caris Mirror Lab. This highly sophisticated system — comparable in size to half a basketball court and containing three times the number of parts of a typical car — is vital to the telescope’s optical performance and precision control. The milestone marks the start of a six-month optical testing phase to demonstrate that the support system can control the mirror as required, validating the revolutionary capabilities ...
Experimental cancer drug eliminates bone metastases caused by breast cancer in lab models
2024-10-15
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.
Patients with breast cancer and bone metastasis have limited treatment options and often rely on palliative care to ease difficult symptoms, including frailty and pain. In most cases, breast cancer with bone metastasis is incurable.
Now, corresponding author Venu Raman, Ph.D., ...